TAK1-inhibitors did not reduce disease burden in a Vκ*MYC model of multiple myeloma.

BMC Res Notes · 2022 · PMC9701378 · PMID 36435864

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Survival data showed a clear trend towards prolonged survival for when mice were treated with 15 or 30 μg/kg TAK1-inhibitors.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.